HOXA10基因敲低对非小细胞肺癌安罗替尼敏感性的影响
李俞羲1, 路遥2, 田野21. 中国医科大学附属第四医院麻醉科, 沈阳 110032;
2. 中国医科大学附属第四医院胸外科, 沈阳 110032
收稿日期:
2021-10-22出版日期:
2022-06-30发布日期:
2022-06-09通讯作者:
田野E-mail:Ono1180@gmail.com作者简介:
李俞羲(1994-),女,医师,硕士.基金资助:
辽宁省自然科学基金(JCZR2020016)关键词: 同源异型盒基因A10, 安罗替尼, 非小细胞肺癌, 敏感性
Abstract: Objective To investigate the effect of homeobox A10(HOXA10)on the sensitivity of non-small cell lung cancer(NSCLC) cell lines to anlotinib. Methods Quantitative real-time PCR was used to determine the expression of HOXA10 mRNA in NSCLC cells. A549 and PC-9 cells were transfected with si-HOXA10,and the expression of HOXA10 protein was detected using Western blotting. The transfected cells were then treated with anlotinib. Cell viability and half-maximal inhibitory concentration(IC50)were determined using the CCK-8 assay. Colony-forming ability was assessed using a colony formation assay. Cell migration and invasion were determined using Transwell assay. Annexin-V/PI staining and flow cytometry were performed to detect cell apoptosis. Results HOXA10 was remarkably upregulated in NSCLC cells. HOXA10 knockdown significantly decreased the IC50 values of anlotinib in both A549 and PC-9 cells. HOXA10 knockdown enhanced the inhibitory effect of anlotinib on colony formation,cell migration,and cell invasion. HOXA10 knockdown promoted anlotinib-induced apoptosis. Conclusion HOXA10 knockdown increases the sensitivity of NSCLC cells to anlotinib.
Key words: homeobox A10, anlotinib, non-small cell lung cancer, sensitivity
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=3007